Source author record

Anthony Gitter

Anthony Gitter appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

5works
8topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2022arXiv

Molecular and Serologic Diagnostic Technologies for SARS-CoV-2

The COVID-19 pandemic has presented many challenges that have spurred biotechnological research to address specific problems. Diagnostics is one area where biotechnology has been critical. Diagnostic tests play a vital role in managing a viral threat by facilitating the detection of infected and/or recovered individuals. From the perspective of what information is provided, these tests fall into two major categories, molecular and serological. Molecular diagnostic techniques assay whether a virus is present in a biological sample, thus making it possible to identify individuals who are currently infected. Additionally, when the immune system is exposed to a virus, it responds by producing antibodies specific to the virus. Serological tests make it possible to identify individuals who have mounted an immune response to a virus of interest and therefore facilitate the identification of individuals who have previously encountered the virus. These two categories of tests provide different perspectives valuable to understanding the spread of SARS-CoV-2. Within these categories, different biotechnological approaches offer specific advantages and disadvantages. Here we review the categories of tests developed for the detection of the SARS-CoV-2 virus or antibodies against SARS-CoV-2 and discuss the role of diagnostics in the COVID-19 pandemic.

preprint2021arXiv

Ten Quick Tips for Deep Learning in Biology

Machine learning is a modern approach to problem-solving and task automation. In particular, machine learning is concerned with the development and applications of algorithms that can recognize patterns in data and use them for predictive modeling. Artificial neural networks are a particular class of machine learning algorithms and models that evolved into what is now described as deep learning. Given the computational advances made in the last decade, deep learning can now be applied to massive data sets and in innumerable contexts. Therefore, deep learning has become its own subfield of machine learning. In the context of biological research, it has been increasingly used to derive novel insights from high-dimensional biological data. To make the biological applications of deep learning more accessible to scientists who have some experience with machine learning, we solicited input from a community of researchers with varied biological and deep learning interests. These individuals collaboratively contributed to this manuscript's writing using the GitHub version control platform and the Manubot manuscript generation toolset. The goal was to articulate a practical, accessible, and concise set of guidelines and suggestions to follow when using deep learning. In the course of our discussions, several themes became clear: the importance of understanding and applying machine learning fundamentals as a baseline for utilizing deep learning, the necessity for extensive model comparisons with careful evaluation, and the need for critical thought in interpreting results generated by deep learning, among others.

preprint2020arXiv

Inferring Signaling Pathways with Probabilistic Programming

Cells regulate themselves via dizzyingly complex biochemical processes called signaling pathways. These are usually depicted as a network, where nodes represent proteins and edges indicate their influence on each other. In order to understand diseases and therapies at the cellular level, it is crucial to have an accurate understanding of the signaling pathways at work. Since signaling pathways can be modified by disease, the ability to infer signaling pathways from condition- or patient-specific data is highly valuable. A variety of techniques exist for inferring signaling pathways. We build on past works that formulate signaling pathway inference as a Dynamic Bayesian Network structure estimation problem on phosphoproteomic time course data. We take a Bayesian approach, using Markov Chain Monte Carlo to estimate a posterior distribution over possible Dynamic Bayesian Network structures. Our primary contributions are (i) a novel proposal distribution that efficiently samples sparse graphs and (ii) the relaxation of common restrictive modeling assumptions. We implement our method, named Sparse Signaling Pathway Sampling, in Julia using the Gen probabilistic programming language. Probabilistic programming is a powerful methodology for building statistical models. The resulting code is modular, extensible, and legible. The Gen language, in particular, allows us to customize our inference procedure for biological graphs and ensure efficient sampling. We evaluate our algorithm on simulated data and the HPN-DREAM pathway reconstruction challenge, comparing our performance against a variety of baseline methods. Our results demonstrate the vast potential for probabilistic programming, and Gen specifically, for biological network inference. Find the full codebase at https://github.com/gitter-lab/ssps

preprint2016arXiv

Unsupervised learning of transcriptional regulatory networks via latent tree graphical models

Gene expression is a readily-observed quantification of transcriptional activity and cellular state that enables the recovery of the relationships between regulators and their target genes. Reconstructing transcriptional regulatory networks from gene expression data is a problem that has attracted much attention, but previous work often makes the simplifying (but unrealistic) assumption that regulator activity is represented by mRNA levels. We use a latent tree graphical model to analyze gene expression without relying on transcription factor expression as a proxy for regulator activity. The latent tree model is a type of Markov random field that includes both observed gene variables and latent (hidden) variables, which factorize on a Markov tree. Through efficient unsupervised learning approaches, we determine which groups of genes are co-regulated by hidden regulators and the activity levels of those regulators. Post-processing annotates many of these discovered latent variables as specific transcription factors or groups of transcription factors. Other latent variables do not necessarily represent physical regulators but instead reveal hidden structure in the gene expression such as shared biological function. We apply the latent tree graphical model to a yeast stress response dataset. In addition to novel predictions, such as condition-specific binding of the transcription factor Msn4, our model recovers many known aspects of the yeast regulatory network. These include groups of co-regulated genes, condition-specific regulator activity, and combinatorial regulation among transcription factors. The latent tree graphical model is a general approach for analyzing gene expression data that requires no prior knowledge of which possible regulators exist, regulator activity, or where transcription factors physically bind.

preprint2011arXiv

A New Computationally Efficient Measure of Topological Redundancy of Biological and Social Networks

It is well-known that biological and social interaction networks have a varying degree of redundancy, though a consensus of the precise cause of this is so far lacking. In this paper, we introduce a topological redundancy measure for labeled directed networks that is formal, computationally efficient and applicable to a variety of directed networks such as cellular signaling, metabolic and social interaction networks. We demonstrate the computational efficiency of our measure by computing its value and statistical significance on a number of biological and social networks with up to several thousands of nodes and edges. Our results suggest a number of interesting observations: (1) social networks are more redundant that their biological counterparts, (2) transcriptional networks are less redundant than signaling networks, (3) the topological redundancy of the C. elegans metabolic network is largely due to its inclusion of currency metabolites, and (4) the redundancy of signaling networks is highly (negatively) correlated with the monotonicity of their dynamics.